MAPS is currently studying the long-term effects of ibogaine treatment on patients presently undergoing therapy at independent ibogaine treatment centers in Mexico and New Zealand.

MAPS is collecting observational data for the first prospective ibogaine outcome studies in order to contribute to the growing scientific literature about ibogaine as a treatment for drug addiction.

https://www.maps.org/research/ibogaine/